Results 161 to 170 of about 370,756 (269)

Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial

open access: yesInternational Journal of Cancer, Volume 156, Issue 11, Page 2178-2187, 1 June 2025.
What's new? Bone metastases are common in a variety of cancer types, causing increased pain and worse outcomes. Suppression of bone turnover, such as with the monoclonal antibody denosumab, results in fewer skeletal complications and improved prognosis. Here, the authors demonstrate the safety and efficacy of a similar antibody, JMT103. Like denosumab,
Ran Ran   +15 more
wiley   +1 more source

Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature

open access: bronze, 2016
Ioannis Christakis   +10 more
openalex   +1 more source

Nonorbital, Nonparameningeal Head and Neck Rhabdomyosarcoma: A Report From the Children's Oncology Group

open access: yesPediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Background Rhabdomyosarcoma (RMS) is the most common pediatric head and neck soft‐tissue sarcoma. Intergroup Rhabdomyosarcoma Study I–IV demonstrated that patients with alveolar RMS (ARMS), Group III disease, or clinically involved regional lymph nodes had a worse prognosis.
Jamie M. Aye   +10 more
wiley   +1 more source

Ferric Carboxymaltose (FCM)–Associated Hypophosphatemia (HPP): A Systematic Review

open access: yesAmerican Journal of Hematology, Volume 100, Issue 5, Page 840-846, May 2025.
ABSTRACT Background Since 2015, ferric carboxymaltose (FCM), an intravenous (IV) iron formulation used for treating iron deficiency anemia (IDA), has been associated with an increasing number of reported hypophosphatemia (HPP) cases. Information on HPP clinical manifestations and incidence has not been reviewed.
Joseph Magagnoli   +4 more
wiley   +1 more source

Evaluation of the metabolism properties of choline kinase alpha in neoplasms of the parathyroid glands. A pilot study

open access: diamond, 2019
Н. Г. Мокрышева   +7 more
openalex   +2 more sources

Inside a Metastatic Fracture: Molecular Bases and New Potential Therapeutic Targets

open access: yesCancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Introduction Bone metastases and pathological fractures significantly impact the prognosis and quality of life in cancer patients. However, clinical and radiological features alone have been shown to fail to predict skeletal related events of a bone metastasis (SREs).
Alessandro Bruschi   +10 more
wiley   +1 more source

Spectrum of mitochondrial genomic variation in parathyroid neoplasms by ultra-deep targeted DNA sequencing

open access: bronze, 2019
Yingying Hu   +8 more
openalex   +1 more source

On TRacK With Larotrectinib in a Neonate With a Giant Congenital ETV6::NTRK3 Fusion‐Positive Infantile Fibrosarcoma of the Head and Neck

open access: yesHead &Neck, Volume 47, Issue 5, Page E50-E57, May 2025.
ABSTRACT Background Infantile fibrosarcoma (IFS) is a rare pediatric tumor of intermediate malignancy with high local aggressiveness that typically presents in young infants. Its occurrence in the head and neck region is rare. Complete non‐mutilating surgical resection is often not possible, requiring multimodal treatment.
Teresa M. Cardesa‐Salzmann   +14 more
wiley   +1 more source

Circular RNA profile of parathyroid neoplasms: analysis of co-expression networks of circular RNAs and mRNAs [PDF]

open access: hybrid, 2019
Ya Hu   +6 more
openalex   +1 more source

Evaluation of Treatment Response and Survival Outcomes in Anaplastic Thyroid Cancer Patients Following Surgery With and Without Other Treatment Modalities: A Systematic Review

open access: yesHealth Science Reports, Volume 8, Issue 5, May 2025.
ABSTRACT Background and Aims Anaplastic thyroid carcinoma (ATC) is a rare type of malignancy ranking among the most aggressive diseases globally, with an extremely poor prognosis. No optimal standardized treatment has been established yet to promote ATC's prognosis and increase the patients' median survival.
Hossein Negahban   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy